FDA approval of Eli Lilly's Alzheimer's drug cements our decision not to profit
Each weekday, the CNBC Investment Club with Jim Cramer publishes The Home Stretch, a handy evening update, just in time…
Jim Cramer
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
The 4 things we're most focused on in the stock market this week
The Nasdaq Composite rose slightly on Friday for its fifth consecutive record close, as new data last week showed a…
9 stocks that can benefit from the Fed's interest rate cuts
The S&P 500 and Nasdaq extended their record rallies this week after consumer inflation data came in better than expected…
Cramer says it's better to come to Oracle, also look at BIRK, JNJ, PARA, CASY
Jim Cramer's daily rapid-fire breaks down stocks in the news outside of the CNBC Investing Club portfolio. Oracle: The tech…
Jim Cramer identifies 5 stocks that can be bought here and now
Let's say you just joined the Club and are trying to determine which stocks we think can be bought right…
Wells Fargo CEO Talks Reasons to Love Stocks, Plus Why the Market is Falling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
We are increasing our geopolitical coverage and a struggling healthcare stock.
We are expanding our only oil reserve and a disadvantaged medical technology company.
Eli Lilly's big investment in GLP-1, plus CRM, BBY, FL and COST earnings next week
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
The stock market is again under attack by the Federal Reserve. Plus, the quiet return of Starbucks
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…